Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) study.

Baddley JW, Winthrop KL, Chen L, Liu L, Grijalva CG, Delzell E, Beukelman T, Patkar NM, Xie F, Saag KG, Herrinton LJ, Solomon DH, Lewis JD, Curtis JR
Ann Rheum Dis. 2014 73 (11): 1942-8

PMID: 23852763 · PMCID: PMC4273901 · DOI:10.1136/annrheumdis-2013-203407

MeSH Terms (17)

Adult Aged Antirheumatic Agents Arthritis, Rheumatoid Autoimmune Diseases Biological Products Biological Therapy Female Humans Immunocompromised Host Immunosuppressive Agents Male Middle Aged Opportunistic Infections Retrospective Studies Tumor Necrosis Factor-alpha United States

Connections (1)

This publication is referenced by other Labnodes entities: